The American Society of Hematology (ASH) released new clinical practice guidelines on Sickle Cell Disease (SCD)-Related Transfusion Support, published in the Society’s peer-reviewed journal Blood Advances.
The guidelines are part of five guidelines on SCD aimed to provide updated treatment guidelines that reflect the newest evidence about the disease, ensuring the medical community can better treat SCD and people with SCD can make the best decisions for their care.
In 2016, ASH initiated an effort to develop clinical practice guidelines on SCD. ASH appointed 61 clinical experts, 5 methodologists and 10 patient representatives to review evidence and form recommendations on SCD. SCD-Related Cardiopulmonary and Kidney Disease Guidelines were previously published by ASH in December 2019.
To learn more about the specific guidelines, and find additional resources, visit the ASH website.